Roueen Rafeyan, M.D.
NPI 1003891458ActiveIndividual· Psychiatry & Neurology, Addiction Medicine· Chicago, IL
Psychiatry & Neurology, Addiction Medicine (M.D.) with Roueen Rafeyan MD Ltd, practicing in Chicago, Illinois. Their prescriptions cost Medicare Part D more than their services did: $512,280 for 629 claims, against $6,440 paid for services in 2024. Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) was the largest of 14 companies reporting payments in 2025, $401,887 in all, mostly speaking and faculty fees.
Overview
| NPI | 1003891458 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Dec 8, 2005 |
| Last updated in NPPES | Nov 21, 2012 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Psychiatry & Neurology, Addiction Medicine Primary | 2084A0401X | 036089152 | IL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Psychiatry (IL) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 40 |
|---|---|
| Services billed | 113 across 6 procedure codes |
| Paid by Medicare | $6,440 |
Part D prescriptions in 2024
| Prescriptions (claims) | 629 · 791 30-day fills |
|---|---|
| Patients | 87 |
| Total drug cost | $512,280 |
| Generic share | 78% of claims |
Education and affiliations
| Graduation year | 1989 |
|---|---|
| Medicare specialty | Psychiatry |
| Secondary specialties | Addiction Medicine |
Medical group
- Roueen Rafeyan MD LtdChicago, IL · 5 clinicians
Industry payments (Open Payments)
- 2025$401,887 · 385 payments from 14 companies
- 2024$369,086 · 396 payments from 14 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) | $84,097 | 82 |
| Neurocrine Biosciences, Inc. | $78,796 | 59 |
| E.R. Squibb & Sons, L.L.C. | $54,108 | 56 |
| Alkermes, Inc. | $53,148 | 56 |
| Teva Pharmaceuticals USA, Inc. | $52,781 | 35 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$313,127 · 96 payments
- Travel and Lodging$32,924 · 97 payments
- Consulting Fee$29,290 · 7 payments
- Honoraria$15,525 · 3 payments
- Food and Beverage$11,021 · 182 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Psychiatry & Neurology, Addiction Medicine providers in Chicago
- 1598361651
- 1063136307
- 1477639078
- 1629553748
- 1700086220
- 1750415261
All Psychiatry & Neurology, Addiction Medicine providers in Illinois →